The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Azilsartan medoxomil/Chlortalidone 40 mg/25 mg Film-coated tablets

40/25 milligram(s) Film-coated tablet

Takeda Pharma A/SPA2167/001/002

Main Information

Trade NameAzilsartan medoxomil/Chlortalidone 40 mg/25 mg Film-coated tablets
Strength40/25 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderTakeda Pharma A/S
Licence NumberPA2167/001/002

Group Information

ATC CodeC09DA Angiotensin II antagonists and diuretics
C09DA09 Angiotensin II Antagonists and Diuretics


Licence Issued04/08/2017
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back